Infosys unveils cloud-based solution for clinical trials

Image
IANS Bangalore
Last Updated : Jun 04 2014 | 10:09 PM IST

India's second largest IT firm Infosys Ltd Wednesday unveiled a cloud-based solution to speed up clinical trials and lower drug development costs.

"The solution helps life sciences companies to accelerate clinical trials by driving greater collaboration between pharmaceutical firms and contract research organisations," the global software major said in a statement here.

As a new version of the clinical trial supply management, the cloud solution will improve productivity of drug development process and ensure timely supply of drugs to patients at lower cost.

"Enterprises using our solution will be able to price their drugs competitively as the software application enables real-time collaboration and helps transform their research and development (R&D) cost model," Infosys' global head for life sciences and services Manish Tandon said in the statement.

As the new version is cloud-based, the solution offers tools to manage the entire supply chain of clinical trials, covering demand and supply, planning and distribution across R&D sites.

A beta version of the solution is in use for clinical trials at some of the global pharma firms in Europe and the US.

"The software product will enable pharma companies to respond faster to changes in demand, based on enrollment and patient turnaround during trials as it can be integrated with enterprise resource planning (ERP) systems, incorporating business processes," Tandon said.

Being cloud-based, the solution will be offered on pay-per-use basis, which will help pharma and biotech firms and contract research units to avoid investing in and managing expensive IT infrastructure for clinical trials.

"With mobility-enabled transactions and remote access capabilities, the solution facilitates real-time data entry for faster decision making," Tandon noted.

The company is showcasing the solution at the three-day 'Sapphire Now' conference being held at Orlando in the US since Tuesday.

"Clinical trials are growing in scale and complexity, driving a need for business processes and systems that integrate the end-to-end activities, decisions and information across business functions," the statement said quoting from a recent Gartner report.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 04 2014 | 9:54 PM IST

Next Story